
到 2025 年亚太地区大麻测试市场 - 按类型(产品和软件)划分的区域分析和预测;服务(效力测试、萜烯分析、农药筛选、残留溶剂筛选、重金属测试、微生物分析和基因测试);最终用户(测试实验室、药品制造商和研究机构)和国家
No. of Pages: 179 | Report Code: TIPRE00003508 | Category: Life Sciences
No. of Pages: 179 | Report Code: TIPRE00003508 | Category: Life Sciences
亚太大麻测试市场预计在预测期内将以最高速度增长,因为亚太地区越来越多地采用 LIMS 以及用于医疗和娱乐目的的大麻合法化。
不断发展的先进技术提供了满足当前要求的最佳解决方案,并使得系统可以根据需要轻松进行调整。现代LIMS(实验室信息管理系统)系统用于自动登记和存档实验室工作结果,以支持人员管理和信息安全。设备和材料管理。进步包括增加创新、管理风险、改善治理、遵守监管要求和提供可量化的运营结果等宏观层面的挑战,帮助病理实验室满足该地区现代病理学服务不断变化的需求。 LIMS 技术的日益普及有助于提高实验室工作状态的透明度,降低成本和成本。提高效率,提供适应新要求的灵活性,并有助于提高质量和质量。遵守。信息技术的渗透以及对数据管理和标准化的需求不断增长,有助于市场上 LIMS 供应商数量的增长。亚洲市场对 LIMS 的需求不断增长,中国和印度等国家的研发支出也在不断增长,相应地推动了该地区的市场增长。
因此由于上述进步,大麻测试市场预计将在预测期内快速增长。
亚太地区预计对大麻测试市场有巨大需求。这是因为大麻在医学上用于治疗各种疾病的患者,例如慢性神经性疼痛和任何脊柱损伤。它还有助于解决艾滋病毒/艾滋病引起的厌食症,这是该地区面临的一项重大挑战。 2018年12月,泰国成为东南亚第一个大麻合法化的国家。对大麻测试实验室的投资大幅增加,最近的法律变化导致人们接受大麻和大麻。
因此,由于大麻日益合法化,大麻测试市场预计将快速增长。
2017 年,按类型划分,该产品领域占据大麻测试市场 73.7% 的最大市场份额。由于医疗保健行业的技术创新,该细分市场预计将在 2025 年主导市场。此外,由于大麻测试中分析服务和药用大麻服务的增加,预计该细分市场 2018 年至 2015 年的复合年增长率将达到 16.1%。
亚太大麻测试市场根据服务分为效力测试、微生物分析、残留溶剂筛查、重金属测试、农药筛查、萜烯分析和基因测试。效力测试领域预计在预测期内复合年增长率为 16.9%。根据测试所在的州,需要检测样品的 THC 和 CBD 水平,以及四氢大麻酚和大麻二酚酸。其他实验室也可能选择测试样本的 CBC 和 CBG。效力测试涉及一系列基质的气相色谱或液相色谱。
测试实验室按最终用户划分,该细分市场占据大麻测试市场 49.2% 的最大市场份额。由于参考实验室对多种疾病进行的诊断测试数量不断增加,预计该细分市场将在 2025 年占据市场主导地位。
战略收购和产品发布被认为是亚太大麻测试行业最常采用的策略。下面列出了最近推出和批准的部分产品:
2016 年:安捷伦科技公司推出 Agilent 5110 ICP-OES,使科学家能够更快、更高效地开展工作精确的ICP-OES分析。
2017年:SCIEX推出X系列四极杆飞行时间(QTOF)质谱(MS)平台X500B QTOF系统。 p>
2018 年:Restek 和 Separation Science 合作开发多发言人电子研讨会,重点关注药用大麻实验室的测试方法和相关主题。
• 亚太地区
Strategic insights for Asia Pacific Cannabis Testing involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2017 | US$ 132.38 Million |
Market Size by 2025 | US$US$ 422.74 Million |
Global CAGR (2018 - 2025) | 15.8% |
Historical Data | 2015-2016 |
Forecast period | 2018-2025 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia Pacific Cannabis Testing refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies
1. Agilent Technologies
2. PerkinElmer, Inc.
3. Shimadzu Corporation
4. SCIEX
5. Merck KGaA
6. Restek Corporation
7. Waters
8. CannaSafe Analytics
9. Accelerated Technology Laboratories, Inc.
10. Digipath Labs
The Asia Pacific Cannabis Testing Market is valued at US$ 132.38 Million in 2017, it is projected to reach US$US$ 422.74 Million by 2025.
As per our report Asia Pacific Cannabis Testing Market, the market size is valued at US$ 132.38 Million in 2017, projecting it to reach US$US$ 422.74 Million by 2025. This translates to a CAGR of approximately 15.8% during the forecast period.
The Asia Pacific Cannabis Testing Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Cannabis Testing Market report:
The Asia Pacific Cannabis Testing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Cannabis Testing Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Cannabis Testing Market value chain can benefit from the information contained in a comprehensive market report.